Clinical Trials on Coronary Stent Restenosis

Total 10578 results

Scripps Health

Completed

SCRIPPS V: Intracoronary Brachytherapy for Recurrent Restenosis After Multiple Drug-Eluting Stents

Coronary Artery Disease | Coronary Restenosis

United States
Abbott Medical Devices

Completed

ABSORB Clinical Investigation, Cohort B (ABSORB B)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

New Zealand, Netherlands, Poland, France, Denmark, Australia, Switzerland, Belgium
Abbott Medical Devices

Completed

To Study the Safety and Clinical Outcomes of the Absorb Bioresorbable Vascular Scaffold (BVS) System in Patients With de Novo Lesions in Previously Untreated Vessels (ABSORB UK)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

United Kingdom
Abbott Medical Devices

Completed

SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Netherlands, Thailand, Israel, Spain, Italy, United Kingdom, Malaysia, Austria, France, Germany, Poland
Abbott Medical Devices

Completed

XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-arm Study (XIENCE V India)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

India
Abbott Medical Devices

Completed

ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary Stent System Clinical Investigation (ABSORB A)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

New Zealand, Denmark, Poland, Netherlands
Abbott Medical Devices

Completed

SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System (SPIRIT II)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Netherlands, Spain, Denmark, Germany, France, Austria, Belgium, India, Italy, New Zealand, Poland, South Africa, Switzerland
Abbott Medical Devices

Completed

SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in Europe (SPIRIT V)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Ireland, Netherlands, Singapore, Spain, China, Belgium, Switzerland, Thailand, Israel, Germany, New Zealand, United Kingdom, Italy, Malaysia, Canada, India, Austria, France, South Africa, Portugal, Czech Republic, Greece, Sweden
Charite University, Berlin, Germany
Techniker Krankenkasse

Completed

Cost-Effectiveness Study in the Reduction of Coronary Restenosis With Sirolimus-Eluting Stents (GERSHWIN)

Coronary Artery Disease

Germany
German Heart Institute
Novartis

Unknown

Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent Implantation

Coronary Artery Disease | Coronary Restenosis

Germany
Kobe City General Hospital
Osaka University; Okayama University; Kobe University; Nagoya University; Kyoto University and other collaborators

Completed

Carotid Artery Stenting With Cilostazol Addition for Restenosis (CAS-CARE)

In-stent Restenosis After Carotid Artery Stenting

Japan
Hemoteq AG

Completed

Comparison of Agent™ and SeQuent® Please Paclitaxel Coated Balloon Catheters in Coronary In-stent Restenosis (AGENT-ISR) (AGENT-ISR)

Coronary Artery Disease | Coronary Arteriosclerosis | Coronary Atherosclerosis | Coronary Restenosis

Germany, France
Arcispedale Santa Maria Nuova-IRCCS
Italian Society of Invasive Cardiology; Associazione Nazionale Medici Cardiologi...

Unknown

The Surgery After Stenting (SAS) Registry (SAS registry)

PERCUTANEOUS CORONARY INTERVENTION | STENTS | SURGERY

Italy
InnoRa GmbH

Completed

Treatment of Coronary In-Stent Restenosis by a Sirolimus (Rapamycin) Coated Balloon or a Paclitaxel Coated Balloon (FIMLIMUSDCB)

DES In-stent Stenosis

Malaysia
University Hospital of Patras

Not yet recruiting

REtrospective Analysis on the Use of COvered Stents for the Treatment of the Dysfunctional Vascular Access (RECOVA)

Study Focuses on the Use of Covered Stents (Stent Grafts) for the Treatment of Dysfunctional Vascular Access of Hemodialysis Patients
Deutsches Herzzentrum Muenchen

Completed

Efficacy Study of Rapamycin- vs. Zotarolimus-Eluting Stents to Reduce Coronary Restenosis (ISAR-TEST-5)

Coronary Heart Disease

Germany
Tampere University
Boston Scientific Corporation

Completed

Prospective Clinical Observational Registry Including Consecutive Patients With In-stent Restenosis or Stent Thrombosis (NIVUS)

Restenosis | Stent Thrombosis

Norway, Sweden, Denmark, Finland, Latvia
Centro de estudios en Cardiologia Intervencionista

Completed

Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents (ORAR III)

Coronary Heart Disease | Coronary Restenosis

Argentina
W.L.Gore & Associates

Completed

GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study

Vascular Stent-Graft Stenosis

Japan
Paul S Teirstein, MD
Cordis Corporation

Completed

The SCRIPPS DES REAL WORLD Registry

Coronary Artery Disease | Coronary Thrombosis | Coronary Restenosis

United States
Herz-Zentrums Bad Krozingen
University Heart Center Freiburg - Bad Krozingen

Withdrawn

Paclitaxel-Coated Versus Uncoated Balloon for Treatment of Below-the-Knee In-Stent-Restenosis (BAIR)

In-stent Stenosis of Infrapopliteal Arteries

Germany
B. Braun Medical International Trading Company...

Completed

A Safety and Efficacy Study of Paclitaxel-eluting Balloon to Paclitaxel-eluting Stent (PEPCAD)

Coronary Instent Restenosis

China
Xuanwu Hospital, Beijing

Unknown

Clinical Study of Stent Versus Direct Atherectomy Versus Angioplasty to Treat Lower Limb In-stent Restenosis

Atherosclerosis | In-stent Arterial Restenosis

China
Medical Care Center Prof. Mathey, Prof. Schofer...

Unknown

The ASSURE ROT Registry: Bioresorbable Vascular Scaffold Following Rotablation for Complex Coronary Lesions (ASSURE ROT)

Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Vascular Diseases | Coronary Artery Disease | Coronary Disease | Arteriosclerosis | Arterial Occlusive Diseases | Coronary Stenosis | Coronary Restenosis

Germany
Radboud University Medical Center
Erasmus Medical Center

Terminated

Esophageal Multisegmented FCSEMS for Malignant Strictures (EATERS)

Oesophageal Cancer | Esophageal Stent Stenosis

Netherlands
Medical Care Center Prof. Mathey, Prof. Schofer...
Abbott Medical Devices

Completed

ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease (ASSURE)

Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Vascular Diseases | Coronary Artery Disease | Coronary Disease | Arteriosclerosis | Arterial Occlusive Diseases | Coronary Stenosis | Coronary Restenosis

Germany
Chugai Pharma USA

Completed

A Blinded Study Conducted at Multiple Centers Evaluating Various Doses of an Investigational Agent (BO-653) Against Placebo, for Safety and Effectiveness in Preventing Post-Angioplasty Blood Vessel Re-Closure (Restenosis) in Stented Vessels.

Atherosclerosis | Coronary Restenosis | Graft Occlusion, Vascular

United States
Institute of Cardiology, Warsaw, Poland

Unknown

Comparison of Safety and Efficacy of Two Different Drug Eluting Stents Implanted Into Saphenous Vein Grafts

Stenosis in Saphenous Vein Graft, Drug Eluting Stent

Poland
China National Center for Cardiovascular Diseases

Recruiting

STrategies of Scheduled Drug-coated Balloons (DCB) Versus Conventional DES for the interveNTional Therapy of de Novo Lesions in Large Coronary vESSels (STENTLESS) Trial (STENTLESS)

De Novo Stenosis | Drug-coated Balloon | Drug-eluting Stent

China
University of Rome Tor Vergata

Unknown

PIoglitazone for PrEvention of Restenosis in Diabetic Patients

Diabetes | Coronary Atherosclerosis | Coronary Restenosis

Italy
Azienda Ospedaliero-Universitaria Careggi

Completed

6-month Intracoronary Optical Coherence Tomography (OCT) Evaluation of Three New Generation Drug Eluting Stent (CREBX-OCT)

Recurrent Angina After Coronary Stent Placement
Chinese PLA General Hospital

Recruiting

Identification of Neoatherosclerosis in ISR Patients Based on Artifical Intelligence

In-stent Restenosis | Neo-atherosclerosis | Retrospective

China
Xuanwu Hospital, Beijing

Enrolling by invitation

Prediction of Hyperperfusion After Carotid Stenting by Multi-parameter Characteristics Based on Cerebral Autoregulation (HACASS)

Dynamic Cerebral Autoregulation | Carotid Artery Stent | Cerebral Artery Stenosis

China
Wake Forest University
Abbott

Completed

Xience V at Wake Forest University Baptist Medical Center (WFUBMC)

Percutaneous Coronary Intervention | Stents

United States
Xuanwu Hospital, Beijing

Unknown

Clinical Study of Excimer Laser and Drug Coated Balloon Versus Excimer Laser and Plain Balloon Versus Plain Balloon and Drug Coated Balloon to Treat Femoropopliteal In-stent Restenosis (Excellent)

Atherosclerosis of Artery | In-stent Arterial Restenosis

China
Central Arkansas Veterans Healthcare System

Not yet recruiting

Rapid Inflation/Deflation Compared With Prolonged High-Pressure Balloon Inflation (INFLATION/DE)

Coronary Artery Disease | Coronary Stent Occlusion

United States
Chung-Ang University
Ulsan University Hospital; Korea University Guro Hospital; Jeju National University... and other collaborators

Unknown

DXR Stent for Vascular Healing and Thrombus Formation: OCT Study

Coronary Artery Disease | Coronary Stent Occlusion

Korea, Republic of
Universitaire Ziekenhuizen KU Leuven
Deutsches Herzzentrum Muenchen; European Union

Unknown

PRESTIGE: PREvention of Stent Thrombosis by an Interdisciplinary Global European Effort (PRESTIGE)

Coronary Artery Stent Thrombosis

Belgium
Viron Therapeutics Inc

Terminated

Serp-1 for the Treatment of Acute Coronary Syndrome

Unstable Angina | Coronary Atherosclerosis | Coronary Restenosis

United States, Canada
Foundation of Cardiovascular Research and Education...

Completed

The Real-World Endeavor Resolute Versus XIENCE V Drug-Eluting Stent Study in Twente (TWENTE)

Coronary Artery Disease | Angina Pectoris | Unstable Angina Pectoris | Coronary Stenosis | Coronary Restenosis

Netherlands
Vascular Investigation Network Spanish Society...

Completed

BS-CERAB TECHNIQUE (BS-CERAB)

Aortoiliac Occlusive Disease | Iliac Artery Stenosis | Stent Complication | Vascular Device Occlusion

Spain
Thorax Centrum Twente

Unknown

Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents (BIONYX)

Coronary Artery Disease | Angina Pectoris | Acute Coronary Syndrome | Unstable Angina Pectoris | Coronary Stenosis | Coronary Restenosis

Netherlands, Israel, Belgium
Corporacion Parc Tauli

Completed

Perioperative Management of Patients With Coronary Stents Undergoing Noncardiac Surgery (RegistStents)

Surgery | Acute Coronary Syndrome | Coronary Stent Occlusion

Spain
Hamilton Health Sciences Corporation
Heart and Stroke Foundation of Canada

Completed

Clinical and Angiographic Outcomes With Hyperglycemic Control Post PCI

Diabetes Mellitus | Coronary Restenosis

Canada
Thorax Centrum Twente

Unknown

DUrable Polymer-based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity (DUTCHPEERS)

Coronary Artery Disease | Angina Pectoris | Acute Coronary Syndrome | Unstable Angina Pectoris | Coronary Stenosis | Coronary Restenosis

Netherlands
Laval University
Quebec Heart Institute

Recruiting

Physiology and Residual Ischemia After Percutaneous Coronary Intervention (EASY-PRIPCI)

Coronary Artery Disease | Chest Pain | Angina Pectoris | Ischemic Heart Disease | Coronary Restenosis

Canada
Shanghai MicroPort Medical (Group) Co., Ltd.

Unknown

Comparison Three vs Twelve Months of Dual Anti-Platelet Therapy After Stent Implantation

Percutaneous Coronary Intervention | Drug-Eluting Stents

China
Careggi Hospital

Completed

Mechanism Of Stent Thrombosis (MOST) Study (Most)

Coronary Artery | Stent Thrombosis | Platelet | Thrombus

Italy
Mayo Clinic

Enrolling by invitation

Optimal Endoscopic Suturing Pattern for Esophageal Stent Fixation

Suture, Complication | Esophageal Stenosis | Stent Migration

United States
Foundation of Cardiovascular Research and Education...

Completed

Comparison of BIOdegradable Polymer and DuRablE Polymer Drug-eluting Stents in an All COmeRs PopulaTion (BIO-RESORT) (BIO-RESORT)

Myocardial Infarction | Coronary Artery Disease | Angina Pectoris | Acute Coronary Syndrome | Angina, Unstable | Coronary Stenosis | Coronary Restenosis

Netherlands

Clinical Trials on Coronary Stent Restenosis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations